Brooks Laboratories Quarterly Results for Trading Insights
BROOKS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹8 Cr
QSept 2025
Brooks Laboratories Quarterly Results Key Highlights
- Revenue of ₹30 Cr in Sept 2025 (+25.0% vs Mar 2025, +42.9% vs Sept 2024)
- Net Profit of ₹8 Cr in Sept 2025 (+500.0% vs Mar 2025, +300.0% vs Sept 2024)
- EBITDA of ₹9 Cr in Sept 2025 (+1000.0% vs Mar 2025)
- Operating Margin of 11.0% in Sept 2025 (+16.0pp vs Mar 2025)
- Earnings Per Share of ₹2.71 in Sept 2025 (+601.9% vs Mar 2025)
Brooks Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 30 | 24 | 33 | 22 | 21 | 25.0% | 42.9% |
| Net Profit (₹ Cr) | 8 | -2 | 10 | 6 | -4 | - | - |
| EBITDA (₹ Cr) | 9 | -1 | 10 | 6 | -3 | - | - |
| EPS (₹) | 2.71 | -0.54 | 3.25 | 1.87 | -1.51 | - | - |
| Operating Margin (%) | 11.0% | -5.0% | 12.0% | 4.0% | -16.0% | - | - |
Brooks Laboratories Share Price Trend Around Quarterly Results
Visualize Brooks Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Brooks Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Brooks Laboratories
Additional stock information and data for BROOKS
Revenue Trend (₹ Cr)
Dec 2025
22
Jun 2025
33
Mar 2025
24
Sept 2025
30
Net Profit Trend (₹ Cr)
Dec 2025
6
Jun 2025
10
Mar 2025
-2
Sept 2025
8
Operating Margin Trend (%)
Dec 2025
4.0%
Jun 2025
12.0%
Mar 2025
-5.0%
Sept 2025
11.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Brooks Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1750.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.7 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6316.0 | 2,860 | 689 | +7.1% | - | 24.1% | 243.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4341.0 | 3,219 | 591 | +11.3% | - | 18.4% | 247.5 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1313.2 | 7,716 | 1,353 | +12.0% | - | 17.5% | 78.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1291.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 79.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores